ABL Bio
298380.KQ
65.00 USD
-0.85
-1.29%
a
Overview
Last close
65.00 usd
Market cap
3.15B usd
52 week high
68.33 usd
52 week low
15.54 usd
Target price
61.34 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
47.1832
Price/Book Value
24.5671
Enterprise Value
3.13B usd
EV/Revenue
45.8606
EV/EBITDA
-32.1061
Key financials
Revenue TTM
68.18M usd
Gross Profit TTM
68.14M usd
EBITDA TTM
-13.93M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
180.43M usd
Net debt
N/A usd
About
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is based in Seoul, South Korea.
- Symbol298380.KQ
- ExchangeKQ
- IsinKR7298380007
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Sang Hoon Lee Ph.D.
- HeadquarterSeoul
- Web sitehttps://www.ablbio.com
